These studies have delineated the role of GPX4 as a crucial regulator of ferroptosis and a potential therapeutic target in cancers, with GPX4 inhibition showing promise, particularly in counteracting tumor growth, therapy resistance, and phenotype differentiation. This evidence concerns the gene GPX4 and neoplasm.